Mark Suett

Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria

John M. Kane, Eran Harary, Roy Eshet et al. · The Lancet Psychiatry · 2023 · 26 citations

Psychiatry, Psychotropic Medication, Pharmacology +7

Management of Schizophrenia with Long-Acting Injectable Antipsychotic Medications: An Assessment of the Educational Needs of Clinicians

Leslie Citrome, Emily Belcher, Sylvie Stacy et al. · Neuropsychiatric Disease and Treatment · 2022 · 24 citations · Full text

Patient and Healthcare Professional Preferences for Characteristics of Long-Acting Injectable Antipsychotic Agents for the Treatment of Schizophrenia

Delbert G. Robinson, Mark Suett, Amanda Wilhelm et al. · Advances in Therapy · 2023 · 17 citations · Full text

Perceived Burdens and Educational Needs of Caregivers of People with Schizophrenia: Results of a National Survey Study

Leslie Citrome, Emily Belcher, Sylvie Stacy et al. · SHILAP Revista de lepidopterología · 2022 · 14 citations · Full text

Early versus late administration of long-acting injectable antipsychotic agents among patients with newly diagnosed schizophrenia: an analysis of a commercial claims database

John M. Kane, Anna Chen, Sangtaeck Lim et al. · International Clinical Psychopharmacology · 2023 · 14 citations · Full text